Literature DB >> 19066381

Patterns of abuse among unintentional pharmaceutical overdose fatalities.

Aron J Hall1, Joseph E Logan, Robin L Toblin, James A Kaplan, James C Kraner, Danae Bixler, Alex E Crosby, Leonard J Paulozzi.   

Abstract

CONTEXT: Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999-2004.
OBJECTIVE: To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths. DESIGN, SETTING, AND PARTICIPANTS: Population-based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006. MAIN OUTCOME MEASURES: Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death (ie, doctor shopping).
RESULTS: Of 295 decedents, 198 (67.1%) were men and 271 (91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 (63.1%) deaths, while 63 (21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [30.9%]) and decedents aged 35 through 44 years (23 [30.7%]) compared with men (33 [16.7%]) and other age groups (40 [18.2%]). Substance abuse indicators were identified in 279 decedents (94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths (79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 (44.4%) had ever been prescribed these drugs.
CONCLUSION: The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066381     DOI: 10.1001/jama.2008.802

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  300 in total

1.  Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study.

Authors:  A Agustí; E Pagès; A Cuxart; E Ballarín; X Vidal; J Teixidor; J Tomás; M M Villar; J-R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

2.  Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.

Authors:  M Soledad Cepeda; Daniel Fife; Wing Chow; Gregory Mastrogiovanni; Scott C Henderson
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

Review 3.  Update in addiction medicine for the generalist.

Authors:  Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

4.  Web-based instruction on substance abuse and drug diversion.

Authors:  Jennifer Reinhold; Laura Pontiggia; Mark Angeles; Grace Earl
Journal:  Am J Pharm Educ       Date:  2010-05-12       Impact factor: 2.047

5.  Medical marijuana use among adolescents in substance abuse treatment.

Authors:  Stacy Salomonsen-Sautel; Joseph T Sakai; Christian Thurstone; Robin Corley; Christian Hopfer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

6.  Prospective, Observational Study of Opioid Use After Hip Arthroscopy for Femoroacetabular Impingement Syndrome.

Authors:  Daniel Cunningham; Brian Lewis; Carolyn Hutyra; Shane Nho; Steven Olson; Richard Mather
Journal:  Arthroscopy       Date:  2018-02-02       Impact factor: 4.772

7.  Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.

Authors:  Abby M Bailey; Daniel P Wermeling
Journal:  Ann Pharmacother       Date:  2014-02-12       Impact factor: 3.154

8.  Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments.

Authors:  Sindhuri Maddineni; Sunil Kumar Battu; Joe Morott; Majumdar Soumyajit; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2013-08-20       Impact factor: 3.765

9.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

Review 10.  Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics.

Authors:  Teresa D Schmidt; J David Haddox; Alexandra E Nielsen; Wayne Wakeland; John Fitzgerald
Journal:  J Behav Health Serv Res       Date:  2015-10       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.